T1	Participants 208 221	COPD patients
T2	Participants 1084 1397	Participants can use any background treatment for COPD except inhaled anticholinergic agents. The study encompasses a wide range of COPD patients, e.g. patients with stable cardiac diseases including arrhythmia can be included. Clinical sites are international and include both primary care as well as specialists
T3	Participants 1416 1498	over 17,000 participants have been randomized from over 1200 sites in 50 countries
